Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)
|
July 27, 2020
Use of a Lariat Capping Ribozyme to Study Cap Function In Vivo
Max Pietschmann, Gregor Tempel, Maral Halladjian, et al.
Human Pathology
|
December 22, 2023
Systematic assessment of tumor necrosis at baseline in cervical cancer - An independent factor associated with poor outcome
Olfa Chouchane-Mlik, Alexandra Oniga, Aurélien Latouche, et al.
Cancer Reports (Hoboken, N.J.)
|
June 13, 2026
Unveiling Candidate Markers for Drug Resistance or Synthetic Lethality in Cervical Cancer: Integrative Analysis of Genetic and Pharmacoprofiling
Suzy Scholl, Elaine Del Nery, Pierre Gestraud, et al.
Nucleic Acids Research
|
February 10, 2017
Functional link between DEAH/RHA helicase Prp43 activation and ATP base binding
Julien Robert-Paganin, Maral Halladjian, Magali Blaud, et al.
The Journal of Pathology
|
July 29, 2024
Pan-cancer evaluation of tumor-infiltrating lymphocytes and programmed cell death protein ligand-1 in metastatic biopsies and matched primary tumors
Zakhia El Beaino, Célia Dupain, Grégoire Marret, et al.
Plos Genetics
|
June 14, 2021
RIOK2 phosphorylation by RSK promotes synthesis of the human small ribosomal subunit
Emilie L Cerezo, Thibault Houles, Oriane Lié, et al.
American Journal of Physiology. Cell Physiology
|
June 24, 2024
The rRNA epitranscriptome and myonuclear SNORD landscape in skeletal muscle fibers contributes to ribosome heterogeneity and is altered by a hypertrophic stimulus
Minying Cui, Paulo Jannig, Maral Halladjian, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 3, 2023
Intratumoral microbiome is driven by metastatic site and associated with immune histopathological parameters: An ancillary study of the SHIVA clinical trial
Marc Hilmi, Maud Kamal, Sophie Vacher, et al.
NAR Cancer
|
October 9, 2025
Reference-free RNA profiling predicts triple negative breast cancer chemoresistance to neoadjuvant treatment
Nouritza Torossian, Marc Gabriel, Panagiotis Papoutsoglou, et al.
BMC Biology
|
February 20, 2024
Tumor mutational burden assessment and standardized bioinformatics approach using custom NGS panels in clinical routine
Célia Dupain, Tom Gutman, Elodie Girard, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Methods in Molecular Biology (Clifton, N.J.)
|
July 27, 2020
Use of a Lariat Capping Ribozyme to Study Cap Function In Vivo
Max Pietschmann, Gregor Tempel, Maral Halladjian, et al.
Human Pathology
|
December 22, 2023
Systematic assessment of tumor necrosis at baseline in cervical cancer - An independent factor associated with poor outcome
Olfa Chouchane-Mlik, Alexandra Oniga, Aurélien Latouche, et al.
Cancer Reports (Hoboken, N.J.)
|
June 13, 2026
Unveiling Candidate Markers for Drug Resistance or Synthetic Lethality in Cervical Cancer: Integrative Analysis of Genetic and Pharmacoprofiling
Suzy Scholl, Elaine Del Nery, Pierre Gestraud, et al.
Nucleic Acids Research
|
February 10, 2017
Functional link between DEAH/RHA helicase Prp43 activation and ATP base binding
Julien Robert-Paganin, Maral Halladjian, Magali Blaud, et al.
The Journal of Pathology
|
July 29, 2024
Pan-cancer evaluation of tumor-infiltrating lymphocytes and programmed cell death protein ligand-1 in metastatic biopsies and matched primary tumors
Zakhia El Beaino, Célia Dupain, Grégoire Marret, et al.
Plos Genetics
|
June 14, 2021
RIOK2 phosphorylation by RSK promotes synthesis of the human small ribosomal subunit
Emilie L Cerezo, Thibault Houles, Oriane Lié, et al.
American Journal of Physiology. Cell Physiology
|
June 24, 2024
The rRNA epitranscriptome and myonuclear SNORD landscape in skeletal muscle fibers contributes to ribosome heterogeneity and is altered by a hypertrophic stimulus
Minying Cui, Paulo Jannig, Maral Halladjian, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 3, 2023
Intratumoral microbiome is driven by metastatic site and associated with immune histopathological parameters: An ancillary study of the SHIVA clinical trial
Marc Hilmi, Maud Kamal, Sophie Vacher, et al.
NAR Cancer
|
October 9, 2025
Reference-free RNA profiling predicts triple negative breast cancer chemoresistance to neoadjuvant treatment
Nouritza Torossian, Marc Gabriel, Panagiotis Papoutsoglou, et al.
BMC Biology
|
February 20, 2024
Tumor mutational burden assessment and standardized bioinformatics approach using custom NGS panels in clinical routine
Célia Dupain, Tom Gutman, Elodie Girard, et al.
Page
of 2